BIOS News and Press, BioPlus Acquisition Corp. From 06/21/19

NEW YORK , June 21, 2019 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City , is investigating: BioScrip, Inc. ( BIOS ) ("BioScrip") rela...

DENVER, June 13, 2019 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip"), the largest independent national provider of infusion and home care management solutions, today announced that key members of BioScrip’s leadership team will continue in executive roles with the com...

Adds Accomplished Independent Director R. Carter Pate to Board and Audit Committee Announces Retirement of Director, James P. Evans, Chair of the Board’s Nominating and Corporate Governance Committee effective September 30, 2019 DENVER, June 10, 2019 (GLOBE NEWSWIRE) -- ...

BioScrip (NASDAQ: BIOS ): Q1 GAAP EPS of -$0.18 misses by $0.07 . More news on: BioScrip, Inc., Earnings news and commentary, Consumer stocks news, , Read more ...

DENVER, May 02, 2019 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced its first quarter 2019 financial results.            ...

History has shown that in every age and in every field of human knowledge, many of the views which almost everyone accepted as true and never bothered to think about further, were in time proven completely wrong. - Phillip Fisher (Warren Buffett's Teacher) The largest profits are usually...

DENVER, April 23, 2019 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today provided an update on its proposed merger with Option Care Enterprises, Inc. (“Optio...

"An investor should act as though he had a lifetime decision card with just twenty punches on it." - The Oracle of Omaha Warren Buffett Merger and acquisition (M&A) research is a highly interesting field for investors due to the substantial potential and the intellectual curiosity th...

Momenta Pharmaceuticals (NASDAQ: MNTA ) initiated with Neutral rating at BTIG Research. More news on: Momenta Pharmaceuticals, Inc., Arcus Biosciences, Inc., Exelixis, Inc., Healthcare stocks news, Stocks on the move, , Read more ...

NEW YORK, NY / ACCESSWIRE / March 18, 2019 / Traders News Source, a leading independent equity researchand corporate access firm focused on small and mid-cap public companies isissuing a comprehensive report on BioScrip Inc. (NASDAQ: BIOS) , a provider of infusion and home care management s...